The present study , using data from the YELLOW trial , was conducted in patients having significant coronary lesions ( fractional flow reserve < 0.8 ) who underwent serial intravascular ultrasound ( IVUS ) and near-infrared spectroscopy ( NIRS ) at baseline and after 7 weeks .